Prior 0 5 0 5 B-treatment
treatment 6 15 6 15 I-treatment
with 16 20 16 20 I-treatment
antitumor 21 30 21 30 I-treatment
vaccines 31 39 31 39 I-treatment
may 40 43 40 43 O
be 44 46 44 46 O
permitted 47 56 47 56 O
upon 57 61 57 61 O
discussion 62 72 62 72 O
with 73 77 73 77 O
the 78 81 78 81 O
medical 82 89 82 89 O
monitor 90 97 90 97 O

Prior 0 5 98 103 B-treatment
treatment 6 15 104 113 I-treatment
with 16 20 114 118 I-treatment
immunotherapy 21 34 119 132 I-treatment
agents 35 41 133 139 I-treatment

Subjects 0 8 140 148 O
must 9 13 149 153 O
be 14 16 154 156 O
at 17 19 157 159 O
the 20 23 160 163 O
recurrent 24 33 164 173 B-treatment
/ 33 34 173 174 I-treatment
metastatic 34 44 174 184 I-treatment
setting 45 52 185 192 I-treatment

Subjects 0 8 193 201 O
must 9 13 202 206 O
have 14 18 207 211 O
histologic 19 29 212 222 O
documentation 30 43 223 236 O
of 44 46 237 239 O
advanced 47 55 240 248 O
recurrent 56 65 249 258 O
or 66 68 259 261 O
metastatic 69 79 262 272 B-cancer
cancer 80 86 273 279 I-cancer

biologic 0 8 280 288 B-treatment
or 9 11 289 291 O
hormonal 12 20 292 300 B-treatment
therapy 21 28 301 308 I-treatment
for 29 32 309 312 O
cancer 33 39 313 319 B-treatment
treatment 40 49 320 329 I-treatment

immunotherapy 0 13 330 343 B-treatment

with 0 4 344 348 O
selected 5 13 349 357 O
advanced 14 22 358 366 O
solid 23 28 367 372 B-cancer
tumors 29 35 373 379 I-cancer

